Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Does Purdue’s Reformulated OxyContin ER Really Deter Abuse? US FDA Panel To Decide
Aug 25 2020
•
By
Brenda Sandburg
FDA advisory committee to review OxyContin ER abuse deterrent data • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers